Sarthak Global Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Sarthak Global Ltd is ₹ 37.8 as of 23 Oct 15:30 . The P/E Ratio of Sarthak Global Ltd changed from 228.2 on March 2024 to 1177 on March 2026 . This represents a CAGR of 72.80% over 3 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Sarthak Global Ltd changed from ₹ 4.11 crore on March 2024 to ₹ 14.13 crore on March 2026 . This represents a CAGR of 50.93% over 3 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Sarthak Global Ltd for the Jun '26 is ₹ 0.09 crore as compare to the Mar '26 revenue of ₹ 4.86 crore. This represent the decline of -98.15% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sarthak Global Ltd for the Jun '26 is ₹ -0.07 crore as compare to the Mar '26 ebitda of ₹ 0.15 crore. This represent the decline of -146% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Sarthak Global Ltd changed from ₹ -0.12 crore to ₹ -0.07 crore over 9 quarters. This represents a CAGR of -21.30% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Sarthak Global Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Sarthak Global Ltd

Sarthak Global Limited was originally incorporated with the Registrar of Companies at Gwalior, in the State of Madhya Pradesh on April 19, 1985 in the name of 'Patel Leasing & Finance Private Limited' by an Industrialist Shri A. C. Patel based at Indore and by Shri V .V. Hirde.
The name of the Company was changed to Avanti Finance Limited on June 23, 1992 and on the same day it was converted into Public Limited Company and the name was changed to Sarthak Global Limited on September 16, 2002. The Company was initially engaged in fund based activities, like investment in equity shares of listed and well known Public Limited Companies.
Thereafter, it diversified into short term money market operations like inter corporate deposits, short term and unsecured advance etc.
But with the crash of share market and crisis in financial market, the Company quickly responded to change and diversified into other areas i.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Sarthak Global Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Sarthak Global Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Sarthak Global Ltd is 11 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Sarthak Global Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Sarthak Global Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sarthak Global Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Sarthak Global Ltd stock price is INR ₹37.8. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Sarthak Global Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Sarthak Global Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.